JPMorgan Chase & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,786
| Closed | -$174K | – | 6698 |
|
|
2024
Q1 | $174K | Buy |
11,786
+4,997
| +74% | +$73.8K | ﹤0.01% | 4504 |
|
|
2023
Q4 | $91K | Buy |
6,789
+2
| +0% | +$27 | ﹤0.01% | 4810 |
|
|
2023
Q3 | $83.7K | Sell |
6,787
-1,557
| -19% | -$19.2K | ﹤0.01% | 4716 |
|
|
2023
Q2 | $103K | Buy |
+8,344
| New | +$103K | ﹤0.01% | 4619 |
|
|
2023
Q1 | – | Sell |
-354
| Closed | -$4K | – | 6412 |
|
|
2022
Q4 | $4K | Buy |
+354
| New | +$4K | ﹤0.01% | 5287 |
|
|
2021
Q3 | – | Sell |
-525
| Closed | -$3K | – | 6002 |
|
|
2021
Q2 | $3K | Buy |
+525
| New | +$3K | ﹤0.01% | 5359 |
|
|
2020
Q4 | – | Sell |
-7
| Closed | – | – | 5339 |
|
|
2020
Q3 | $0 | Sell |
7
-674
| -99% | – | ﹤0.01% | 5243 |
|
|
2020
Q2 | $2K | Sell |
681
-10,476
| -94% | -$30.8K | ﹤0.01% | 4653 |
|
|
2020
Q1 | $24K | Buy |
11,157
+732
| +7% | +$1.58K | ﹤0.01% | 4319 |
|
|
2019
Q4 | $33K | Buy |
10,425
+10,325
| +10,325% | +$32.7K | ﹤0.01% | 4346 |
|
|
2019
Q3 | $0 | Sell |
100
-27
| -21% | – | ﹤0.01% | 5066 |
|
|
2019
Q2 | $1K | Sell |
127
-42,286
| -100% | -$333K | ﹤0.01% | 4806 |
|
|
2019
Q1 | $232K | Sell |
42,413
-28,679
| -40% | -$157K | ﹤0.01% | 3704 |
|
|
2018
Q4 | $216K | Buy |
71,092
+1,068
| +2% | +$3.25K | ﹤0.01% | 3781 |
|
|
2018
Q3 | $294K | Buy |
70,024
+69,897
| +55,037% | +$293K | ﹤0.01% | 3729 |
|
|
2018
Q2 | $0 | Sell |
127
-3,736
| -97% | – | ﹤0.01% | 4986 |
|
|
2018
Q1 | $25K | Sell |
3,863
-175
| -4% | -$1.13K | ﹤0.01% | 4367 |
|
|
2017
Q4 | $32K | Buy |
4,038
+3,631
| +892% | +$28.8K | ﹤0.01% | 4280 |
|
|
2017
Q3 | $4K | Buy |
407
+43
| +12% | +$423 | ﹤0.01% | 4166 |
|
|
2017
Q2 | $3K | Sell |
364
-28,408
| -99% | -$234K | ﹤0.01% | 4220 |
|
|
2017
Q1 | $697K | Sell |
28,772
-3,639
| -11% | -$88.2K | ﹤0.01% | 3032 |
|
|
2016
Q4 | $1.04M | Buy |
32,411
+2,738
| +9% | +$87.9K | ﹤0.01% | 2968 |
|
|
2016
Q3 | $1.48M | Sell |
29,673
-2,448
| -8% | -$122K | ﹤0.01% | 2597 |
|
|
2016
Q2 | $1.36M | Sell |
32,121
-9,725
| -23% | -$412K | ﹤0.01% | 2627 |
|
|
2016
Q1 | $2.76M | Sell |
41,846
-15
| -0% | -$988 | ﹤0.01% | 2237 |
|
|
2015
Q4 | $2.6M | Sell |
41,861
-3,653
| -8% | -$227K | ﹤0.01% | 2261 |
|
|
2015
Q3 | $3.05M | Buy |
45,514
+13,432
| +42% | +$899K | ﹤0.01% | 2196 |
|
|
2015
Q2 | $3.12M | Sell |
32,082
-1,407
| -4% | -$137K | ﹤0.01% | 2308 |
|
|
2015
Q1 | $3.13M | Buy |
33,489
+108
| +0.3% | +$10.1K | ﹤0.01% | 2333 |
|
|
2014
Q4 | $2.97M | Sell |
33,381
-10,326
| -24% | -$918K | ﹤0.01% | 2315 |
|
|
2014
Q3 | $3.02M | Sell |
43,707
-918
| -2% | -$63.4K | ﹤0.01% | 2235 |
|
|
2014
Q2 | $2.56M | Sell |
44,625
-3,048
| -6% | -$175K | ﹤0.01% | 2344 |
|
|
2014
Q1 | $1.89M | Buy |
47,673
+4,182
| +10% | +$166K | ﹤0.01% | 2516 |
|
|
2013
Q4 | $1.82M | Sell |
43,491
-6,250
| -13% | -$262K | ﹤0.01% | 2602 |
|
|
2013
Q3 | $1.48M | Buy |
49,741
+5,163
| +12% | +$154K | ﹤0.01% | 2760 |
|
|
2013
Q2 | $2.36M | Buy |
+44,578
| New | +$2.36M | ﹤0.01% | 2441 |
|